StonvexLoading…
StonvexStonvexStonvexCore line items from WAY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $313.87M | $1.10B | $795.74M | $527.09M |
Operating Income | $80.47M | $249.31M | $190.29M | $130.06M |
Net Income | $43.28M | $112.09M | $92.10M | $61.45M |
EPS (Diluted) | $0.22 | $0.61 | $0.51 | $0.34 |
Total Assets | $5.84B | $5.79B | $4.75B | $4.68B |
Total Liabilities | $1.90B | $1.91B | $1.52B | $1.50B |
Cash & Equivalents | $34.34M | $61.35M | $421.06M | $290.30M |
Free Cash Flow OCF − CapEx | $69.59M | $283.19M | $225.97M | $149.82M |
Shares Outstanding | 191.69M | 191.59M | 174.67M | 174.15M |